Presbycusis
21
2
2
14
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 21 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
57%
8 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (21)
Evaluation of the Impact of Cochlear Implants on Cognition in Older Adults
Age-related Hearing Loss and Lexical Disorders
Efficacy and Safety of Liuwei Dihuang Pill Versus Placebo in Presbycusis With Shen (Kidney)-Yin Deficiency
Clinical Trial on Alzheimer Disease, Presbycusis and Hearing Aids
Improving Speech in Noise Perception for Individuals With Age-related Hearing Loss
Audiovestibular Function in Infratentorial Superficial Siderosis
Barriers and Facilitators to OTC Hearing Aids Success
Impact of Hearing Aid Service-delivery Model and Technology on Patient Outcomes
Effects of Huperzine a on Presbycusis(Δ,kHz, DB,MMSE, AD)
Longitudinal Outcomes of Hearing Aids
Hearing and Cognition in Aging Adults
FX-322 in Adults With Age-Related Sensorineural Hearing Loss
Study of the Association Between Presbycusis With the Incidence of Frailty
Impact of Auditory Stimulation in Eating Pleasure (EDERE 2021)
Variability In Hearing Aid Outcomes In Older Adults
Evaluating Hearing Aid Service Delivery Models
At-home Auditory Training Clinical Trial
Mitochondrial Genetics of Presbycusis
Computer-Based Auditory Rehabilitation
Predicting Success With Hearing Aids